Please note that trial statuses change frequently, call us for the most up-to-date information about enrolling in a clinical trial.
The Jordan Research and Education Institute (REDI)
2450 Ashby Avenue
Berkeley, CA 94705
(510) 486-8371 fax
Breast Cancer Clinical Trial
The purpose of this study is to compare the efficacy of a single dose of SPI-2012 with pegfilgrastim (Neulasta [NDC 55513-190-01] manufactured by Amgen) in patients with early-stage breast cancer receiving docetaxel and cyclophosphamide (TC), as measured by the Duration of Severe Neutropenia (DSN) in Cycle 1.